[{"type": "title", "data": "=Attributes!B2"}, {"type": "category", "data": "Medications"}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "See BCCH Transplant Therapeutic Drug Monitoring Guidelines", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Assess patient's baseline creatinine and eGFR", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "TACrolimus", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Titrate TACrolimus to the specified patient target and schedule repeat testing, as per BCCH Transplant Therapeutic Drug Monitoring Guidelines"}, {"type": "order", "data": "Notify Treating Provider", "value": ""}, {"type": "sentence", "data": "For TACrolimus level: 1) more than 1 ng/mL above or below target, or 2) out-of-range on two consecutive tests, or 3) if risk factors for altered drug metabolism"}, {"type": "note", "data": "TACrolimus long acting", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Titrate TACrolimus long acting to the specified patient target and schedule repeat testing, as per BCCH Transplant Therapeutic Drug Monitoring Guidelines"}, {"type": "order", "data": "Notify Treating Provider", "value": ""}, {"type": "sentence", "data": "For TACrolimus level: 1) more than 1 ng/mL above or below target, or 2) out-of-range on two consecutive tests, or 3) if risk factors for altered drug metabolism"}, {"type": "note", "data": "SIrolimus ", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Titrate SIrolimus to the specified patient target and schedule repeat testing, as per BCCH Transplant Therapeutic Drug Monitoring Guidelines"}, {"type": "order", "data": "Notify Treating Provider", "value": ""}, {"type": "sentence", "data": "For SIrolimus level: 1) more than 1 ng/mL above or below target, or 2) out-of-range on two consecutive tests, or 3) if risk factors for altered drug metabolism"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}]
